Pharmamar

This phase 3 study tests two experimental treatments—lurbinectedin alone or combined with irinotecan—against standard options (topotecan or irinotecan) in 705 adults with small cell lung cancer that returned after one prior chemotherapy. The goal is to see if these new approaches…